References
- Fagan C J, Swischuck L E. The opaque lung in lobar emphysema. Am J Roentgenol 1972; 114: 300
- Eraklis A J, Griscom N T, McGovern J B. Bronchogenic cysts of the mediastinum in infancy. N Engl J Med 1969; 281: 1150
- Caffey J. J Pediatric X-Ray Diagnosis, ed 7. Year Book Medical Publishers Inc., Chicago 1978
- Larsson S, Svedmyr N. Cumulative dose response curves for comparison of oral bronchodilating drugs. Ann Allergy 1977; 39: 362
- Chervinsky P. A comparative evaluation of fenoterol and terbutaline in the treatment of asthma. Ann Allergy 1978; 40: 189
- Trembath P W, et al. Comparison of four weeks treatment with fenoterol and terbutaline aerosol in adult asthmatics. A double-blind crossover study. J Allergy Clin Immunol 1979; 63: 395
- Campbell I A, et al. Comparison of salmefamol and salbutamol in patients with chronic airways obstruction. Br J Clin Pharmacol 1976; 3: 151
- Silett R W, et al. Comparison of salmefamol with salbutamol aerosols in asthmatics. Eur J Clin Pharmacol 1976; 9: 277
- Minatoya H. Studies on bitolterol, Di-p-toluate ester of N-terbutyl arterenol: A new long-acting bronchodilator with reduced cardiovascular effects. J Pharmacol Exp Ther 1978; 206: 515
- Larsson S, Svedmy N. Comparison of intravenous ibuterol (KWD 2058), a new bronchodilator, and terbutaline. Eur J Clin Pharmacol 1977; 22: 429
- Baronti A, et al. A comparison between inhaled clenbuterol and salbutamol in chronic bronchitis with reversible airway obstruction. Eur J Respir Dis 1980; 62: 143
- Moore P F, et al. Pirbuterol, a selective beta-2 adrenergic bronchodilator. J Pharmacol Exp Ther 1978; 207: 410
- Zanetti C L, et al. Efficacy and duration of action of procaterol, a new bronchodilator. J Clin Pharmacol 1982; 22: 250
- Ellis E F. Theophylline and derivatives. Allergy: Principles and Practice, E Middleton, C E Reed, E F Ellis. The CV Mosby Co, St Louis 1978
- Weinberger M, Hendeles L. Practical guide to using theophylline. J Respir Dis 1981; 2(7)12–27
- Bonham A, Hendeles L, Vaughan L, Weinberger M. The reliability of serum theophylline determinations from clinical laboratories. Am Rev Respir Dis 1980; 122: 829
- Szefler S J. Using serum measurements to tailor theophylline therapy. J Respir Dis., to be published
- Berquist W E, Rachelesky G S, Kadden M., et al. Gastroesophageal reflux-associated recurrent pneumonia and chronic asthma in children. Pediatrics 1981; 68: 29–35
- Euler A R, Byrne W J, Rachelesky G S, et al. Recurrent pulmonary disease in children: A complication of gastroesophageal reflux. Pediatrics 1979; 63: 47–51
- Cohen S, Snape W J. The pathophysiology and treatment of gastroesophageal reflux disease. Arch Intern Med 1978; 138: 1398
- Herbst J J. Gastroesophageal reflux. J Pediatr 1981; 98: 859–870
- Richter J E, Castell D O. Gastroesophageal reflux: Pathogenesis, diagnosis and therapy. Ann Intern Med 1982; 97: 93–102
- Berquist W E, Rachelefsky G S. Gastroesophageal reflux. Pediatric Respiratory Disorders, E Nussbaum, S Galant. Academic Press Inc, San Diego 1983
- Itkin I H, Menzel M L. The use of macrolide antibotic substances in the treatment of asthma. J Allergy 1970; 45: 146–62
- Spector S L, Katz F H, Farr R S. Troleandomydn: Effectiveness in steroid-dependent asthma and bronchitis. J Allergy Clin Immunol 1974; 54: 367–379
- Weinberger M, Hudgel D, Spector S L, Chidsey C. Inhibition of theophylline clearance by troleandomycin. J Allergy Clin Immunol 1977; 59: 228–231
- Zeiger R S, Schatz M, Spering W, et al. Efficacy of troleandomycin in outpatients with severe corticosteroid-dependent asthma. J Allergy Clin Immunol 1980; 66: 438–446
- Szefier S J, Ellis E F, Brenner M, et al. Steroid-specific and anticonvulsant interaction aspects of troleandomycinsteroid therapy. J. Allergy Clin. Immunol 1982; 69: 455–460